Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: SARS-CoV-2 variants supplement stream 1

University of Calgary

$50,000.00

COVID-19 Variant Supplement - Development and implementation of rapid metagenomic sequencing coupled with isothermal amplification point of care testing for viral diagnostics

EF 2020-21

Résumé
Infectious pandemics or plagues have altered human history since the beginning of time. Today we face the threat of viral pandemics spreading through human populations disseminated fueled by the ease of international travel which has become commonplace. SARS, influenza, and now the 2109 novel coronavirus are examples of just a few of these pandemics. We must create novel tools that enable us to rapidly identify the virus and then develop a test that can reliably test for the virus in patients. The test has to be portable and taken to the bedside where patients are quarantined so that these individuals do not further transmit viruses in our hospitals and public places.
Programme
Operating Grant: SARS-CoV-2 variants supplement stream 1
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
443279
Name
Pillai Dylan R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
COVID-19 Variant Supplement - Development and implementation of rapid metagenomic sequencing coupled with isothermal amplification point of care testing for viral diagnostics
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Operating Grant: SARS-CoV-2 variants supplement stream 1
Keyworddelim
Bioinformatics; Loop Mediated Amplification; Molecular Diagnostics; Point Of Care Testing; Whole Genome Sequencing
Abstract
Infectious pandemics or plagues have altered human history since the beginning of time. Today we face the threat of viral pandemics spreading through human populations disseminated fueled by the ease of international travel which has become commonplace. SARS, influenza, and now the 2109 novel coronavirus are examples of just a few of these pandemics. We must create novel tools that enable us to rapidly identify the virus and then develop a test that can reliably test for the virus in patients. The test has to be portable and taken to the bedside where patients are quarantined so that these individuals do not further transmit viruses in our hospitals and public places.
Competitiondate
202102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pillai, Dylan R; Chiu, Charles Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~